Electrically-assisted nucleic acids delivery to tissues in vivo: Where do we stand?

Current Pharmaceutical Design

Volumn 12, Issue 29, 2006, Pages 3817-3825

  Cemazar, M ^a,b   Golzio, M ^a   Sersa, G ^b   Rols, M P ^a   Teissié, Justin ^a  

^a INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

^b INSTITUTE OF ONCOLOGY   (Slovenia)

Author keywords

Animal models; Electric field distribution; Electrogene therapy; Electropermeabilization; Electroporation; Electropulsation; Non viral gene delivery; Plasmid DNA

Indexed keywords

ENDOTOXIN; NAKED DNA; NUCLEIC ACID; PLASMID DNA; VIRUS VECTOR;

BLOOD FLOW; DNA TRANSFER; ELECTRIC FIELD; ELECTRODE; ELECTROPORATION; EXTRACELLULAR SPACE; GENE CONSTRUCT; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENETIC TRANSFECTION; IMMUNE RESPONSE; IMMUNOGENICITY; IN VIVO STUDY; INFLAMMATION; METHODOLOGY; NONHUMAN; PLASMID; PRIORITY JOURNAL; REPRODUCIBILITY; REVIEW; TISSUE INJURY;

AGE FACTORS; ANIMALS; DNA; ELECTROPORATION; ENZYMES; EXTRACELLULAR MATRIX; GENE THERAPY; HUMANS; LIPOSOMES; MUSCLE, SKELETAL; NEOPLASMS, EXPERIMENTAL; NUCLEIC ACIDS; PLASMIDS; SEX FACTORS; TRANSFECTION;

EID: 33749827108     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161206778559740     Document Type: Review

References (112)

1. Sersa G, Cemazar M, Rudolf Z. Electrochemotherapy: advantages and drawbacks in treatment of cancer patients. Cancer Therapy 2003; 1: 133-142.
2. Gothelf A, Mir LM, Gehl J. Electrochemotherapy: results of cancer treatment using enhanced delivery of bleomycin by electroporation. Cancer Treat Rev 2003; 29: 371-87.
3. Aihara H, Miyazaki J. Gene transfer into muscle by electroporation in vivo. Nat Biotechnol 1998; 16: 867-870.
4. Mir LM, Bureau MF, Gehl J, Rangara R, Rouy D, Caillaud JM, et al. High-efficiency gene transfer into skeletal muscle mediated by electric pulses. Proc Natl Acad Sci USA 1999; 96: 4262-4267.
5. Rols MP, Delteil C, Golzio M, Dumond P, Cros S, Teissie J. In vivo electrically mediated protein and gene transfer in murine melanoma. Nat Biotechnol 1998; 16: 168-171.
6. Heller R, Jaroszeski M, Atkin A, Moradpour D, Gilbert R, Wands J, et al. In vivo gene electroinjection and expression in rat liver. FEBS Lett 1996; 389: 225-228.
7. Nishi T, Yoshizato Y, Yamashiro S, Takeshima H, Sato K, Hamada K, et al. High-efficiency in vivo gene transfer using intraarterial plasmid DNA injection following in vivo electroporation. Cancer Res 1996; 56: 1050-1055.
8. Titomirov A, Sukarev S, Kistanova E. In vivo electroporation and stable transformation of skin cells of newborn mice by plasmid DNA. Biochim Biophys Acta 1991; 1088: 131-134.
9. Andre F, Mir LM. DNA electrotransfer: its principles and an updated review of its therapeutic applications. Gene Ther 2004; 11 Suppl 1: S33-42.
10. McMahon JM, Wells DJ. Electroporation for gene transfer to skeletal muscles: current status. Bio-Drugs 2004; 18: 155-165.
11. Bloquel C, Fabre E, Bureau MF, Scherman D. Plasmid DNA electrotransfer for intracellular and secreted proteins expression: new methodological developments and applications. J Gene Med 2004; 6 Suppl 1: S11-23.
12. Li S. Electroporation gene therapy: new developments in vivo and in vitro. Curr Gene Ther 2004; 4: 309-316.
13. Trezise AE, Palazon L, Davies WL, Colledge WH. In vivo gene expression: DNA electrotransfer. Curr Opin Mol Ther 2003; 5: 397-404.
14. Neumann E, Rosenheck K. Permeability changes induced by electric impulses in vesicular membranes. J Membr Biol 1972; 10: 279-290.
15. Neumann E, Schaefer-Ridder M, Wang Y, Hofschneider PH. Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J 1982; 1: 841-845.
16. Wolf H, Rols MP, Boldt E, Neumann E, Teissie J. Control by pulse parameters of electric field-mediated gene transfer in mammalian cells. Biophys J 1994; 66: 524-531.
17. Golzio M, Teissie J, Rols MP. Direct visualization at the single-cell level of electrically mediated gene delivery. Proc Natl Acad Sci USA 2002; 99: 1292-1297.
18. Rols MP, Teissie J. Electropermeabilization of mammalian cells. Quantitative analysis of die phenomenon. Biophys J 1990; 58: 1089-1098.
19. Eynard N, Rols M, Ganeva V, Galutzo B, Sabri N, Teissié J. Electrotransformation pathways of procaryotic and eucaryotic cells: recent developments. Bioelectrochem Bioenerg 1997; 44: 103-110.
20. Dean DA, Machado-Aranda D, Blair-Parks K, Yeldandi AV, Young JL. Electroporation as a method for high-level nonviral gene transfer to the lung. Gene Ther 2003; 10: 1608-1615.
21. Dezawa M, Takano M, Negishi H, Mo X, Oshitari T, Sawada H. Gene transfer into retinal ganglion cells by in vivo electroporation: a new approach. Micron 2002; 33: 1-6.
22. Lin CR, Tai MH, Cheng JT, Chou AK, Wang JJ, Tan, PH, et al. Electroporation for direct spinal gene transfer in rats. Neurosci Lett 2002; 317: 1-4.
23. Blair-Parks K, Weston BC, Dean DA. High-level gene transfer to the cornea using electroporation. J Gene Med 2002; 4: 92-100.
24. Tsujie M, Isaka Y, Nakamura H, Imai E, Hori M. Electroporation-mediated gene transfer that targets glomeruli. J Am Soc Nephrol 2001; 12: 949-954.
25. Inoue T, Krumlauf R. An impulse to the brain - using in vivo electroporation. Nat Neurosci 2001; 4 Suppl: 1156-1158.
26. Ohashi S, Kubo T, Kishida T, Ikeda T, Takahashi K, Arai Y, et al. Successful genetic transduction in vivo into synovium by means of electroporation. Biochem Biophys Res Commun 2002; 293: 1530-1535.
27. Grossin L, Cournil-Henrionnet C, Mir LM, Liagre B, Dumas D, Etienne S, et al. Direct gene transfer into rat articular cartilage by in vivo electroporation. Faseb J 2003; 17: 829-835.
28. Muller F, Lele Z, Varadi L, Menczel L, Orban L. Efficient transient expression system based on square pulse electroporation and in vivo luciferase assay of fertilized fish eggs. FEBS Lett 1993; 324: 27-32.
29. Muramatsu T, Shibata O, Ryoki S, Ohmori Y, Okumura J. Foreign gene expression in the mouse testis by localized in vivo gene transfer. Biochem Biophys Res Comm 1997: 233: 45-49.
30. Harimoto K, Sugimura K, Lee CR, Kuratsukuri K, Kishimoto T. In vivo gene transfer methods in the bladder without viral vectors. Br J Urol 1998; 81: 870-874.
31. Sugimura K, Harimoto K, Kishimoto T. In vivo gene transfer methods into bladder without viral vectors. Hinyokika Kiyo 1997; 43: 823-827.
32. Matsumoto T, Komori K, Shoji T, Kuma S, Kume M, Yamaoka T, et al. Successful and optimized in vivo gene transfer to rabbit carotid artery mediated by electronic pulse. Gene Ther 2001; 8: 1174-1179.
33. Jayankura M, Boggione C, Frisen C, Boyer O, Fouret P, Saillant G, et al. In situ gene transfer into animal tendons by injection of naked DNA and electrotransfer. J Gene Med 2003; 5: 618-624.
34. Golzio M, Rols MP, Gabriel B, Teissie J. Optical imaging of in vivo gene expression: a critical assessment of the methodology and associated technologies. Gene Ther 2004; 11 Suppl 1: S85-91.
35. Hoffman RM. In vivo imaging with fluorescent proteins: the new cell biology. Acta Histochem 2004; 106: 77-87.
36. Yin D, Tang JG. Gene therapy for streptozotocin-induced diabetic mice by electroporational transfer of naked human insulin precursor DNA into skeletal muscle in vivo. FEBS Lett 2001; 495: 16-20.
37. Rizzuto G, Cappelletti M, Maione D, Savino R, Lazzaro D, Costa P, et al. Efficient and regulated crythropoietin production by naked DNA injection and muscle electroporation. Proc Natl Acad Sci USA 1999; 96: 6417-6422.
38. Selby M, Goldbeck C, Pertile T, Walsh R, Ulmer J. Enhancement of DNA vaccine potency by electroporation in vivo. J Biotechnol 2000; 83: 147-152.
39. Widera G, Austin M, Rabussay D, Goldbeck C, Barnett SW, Chen M, et al. Increased DNA vaccine delivery and immunogenicity by electroporation in vivo. J Immunol 2000; 164: 4635-4640.
40. Niu G, Heller R, Catlett-Falcone R, Coppola D, Jaroszeski M, Dalton W, et al. Gene therapy with dominant-negative Stat3 suppresses growth of the murine melanoma B16 tumor in vivo. Cancer Res 1999; 59: 5059-5063.
41. Suzuki T, Shin BC, Fujikura K, Matsuzaki T, Takata K. Direct gene transfer into rat liver cells by in vivo electroporation. FEBS Lett 1998; 425: 436-440.
42. Lucas ML, Heller R. Immunomodulation by electrically enhanced delivery of plasmid DNA encoding IL-12 to murine skeletal muscle. Mol Ther 2001; 3: 47-53.
43. Molnar MJ, Gilbert R, Lu Y, Liu AB, Guo A, Larochelle N, et al. Factors influencing the efficacy, longevity, and safety of electroporation-assisted plasmid-based gene transfer into mouse muscles. Mol Ther 2004; 10: 447-455.
44. Gehl J, Mir LM. Determination of optimal parameters for in vivo gene transfer by electroporation, using a rapid in vivo test for cell permeabilization. Biochem Biophys Res Commun 1999; 261: 377-380.
45. Jaroszeski MJ, Gilbert RA, Heller R. In vivo antitumor effects of electrochemotherapy in a hepatoma model. Biochim Biophys Acta 1997;1334: 15-18.
46. Ramirez LH, Orlowski S, An D, Bindoula, G, Dzodic R, Ardouin P, et al. Electrochemotherapy on liver tumours in rabbits. Br J Cancer 1998; 77: 2104-2111.
47. Gilbert RA, Jaroszeski MJ, Heller R. Novel electrode designs for electrochemotherapy. Biochim Biophys Acta 1997; 1334: 9-14.
48. Miklavic D, Beravs K, Semrov D, Cemazar M, Demsar F, Sersa G. The importance of electric field distribution for effective in vivo electroporation of tissues. Biophys J 1998; 74: 2152-2158.
49. Dev SB, Dhar D, Krassowska W. Electric field of a six-needle array electrode used in drug and DNA delivery in vivo: analytical versus numerical solution. IEEE Trans Biomed Eng 2003; 50: 1296-1300.
50. Semrov D, Miklavcic D. Calculation of the electrical parameters in electrochemotherapy of solid tumours in mice. Comput Biol Med 1998; 28: 439-448.
51. Brandisky K, Daskalov I. Electrical field and current distributions in electrochemotherapy. Bioelectrochem Bioenerg 1999; 48: 201-208.
52. Miklavcic D, Semrov D, Mekid H, Mir LM. A validated model of in vivo electric field distribution in tissues for electrochemotherapy and for DNA electrotransfer for gene therapy. Biochim Biophys Acta 2000; 1523: 73-83.
53. Sel D, Mazeres S, Teissie J, Miklavcic D. Finite-element modeling of needle electrodes in tissue from the perspective of frequent model computation. IEEE Trans Biomed Ena 2003; 50: 1221-1232.
54. Gowrishankar TR, Weaver JC. An approach to electrical modeling of single and multiple cells. Proc Natl Acad Sci USA 2003; 100: 3203-3208.
55. Kinosita KJr, Tsong TY. Voltage-induced conductance in human erythrocyte membranes. Biochim Biophys Acta 1979; 554: 479-497.
56. Abidor IG, Li LH, Hui SW. Studies of cell pellets: II. Osmotic properties, electroporation, and related phenomena: membrane interactions. Biophys J 1994; 67: 427-435.
57. Kinosita KJr, Tsong TY. Formation and resealing of pores of controlled sizes in human erythrocyte membrane. Nature 1977; 268: 438-441.
58. Golzio M, Mora MP, Raynaud C, Delteil C, Teissie J, Rols MP. Control by osmotic pressure of voltage-induced permeabilization and gene transfer in mammalian cells. Biophys J 1998; 74: 3015-3022.
59. Deng J, Schoenbach KH, Buescher ES, Hair PS, Fox PM, Beebe SJ. The effects of intense submicrosecond electrical pulses on cells. Biophys J 2003; 84: 2709-2714.
60. Pavlin M, Pavselj N, Miklavcic D. Dependence of induced transmembrane potential on cell density, arrangement, and cell position inside a cell system. IEEE Trans Biomed Eng 2002; 49:605-612.
61. Gehl J, Sorensen TH Nielsen K, Raskmark P, Nielsen SL, Skovsgaard T, et al. In vivo electroporation of skeletal muscle: threshold, efficacy and relation to electric field distribution. Biochim Biophys Acta 1999; 1428: 233-240.
62. Cemazar M, Sersa G, Wilson J, Tozer GM, Hart SL Grosel A, et al. Effective gene transfer to solid tumors using different nonviral gene delivery techniques: electroporation, liposomes, and integrin-targeted vector. Cancer Gene Ther 2002; 9: 399-406.
63. Heller LC, Coppola D. Electrically mediated delivery of vector plasmid DNA elicits an antitumor effect. Gene Ther 2002; 9: 1321-1325.
64. Dona M, Sandri M, Rossini K, Dell'Aica I, Podhorska-Okolow M, Carraro U. Functional in vivo gene transfer into the myofibers of adult skeletal muscle. Biochem Biophys Res Commun 2003; 312: 1132-1138.
65. Babiuk S, Baca-Estrada ME, Foldvari M, Baizer L, Stout R, Storms M, et al. Needle-free topical electroporation improves gene expression from plasmids administered in porcine skin. Mol Ther 2003; 8: 992-998.
66. Zhang L, Nolan E, Kreitschitz S, Rabussay DP. Enhanced delivery of naked DNA to the skin by non-invasive in vivo electroporation. Biochim Biophys Acta 2002; 1572: 1-9.
67. Liu F, Huang L. A syringe electrode device for simultaneous injection of DNA and electrotransfer. Mol Ther 2002; 5: 323-328.
68. Hartikka J, Sukhu L, Buchner C, Hazard, D, Bozoukova V, Margalith M, et al. Electroporation-facilitated delivery of plasmid DNA in skeletal muscle: plasmid dependence of muscle damage and effect of poloxamer 188. Mol Ther 2001; 4: 407-415.
69. Durieux AC, Bonnefoy R, Busso T, Freyssenet D. In vivo gene electrotransfer into skeletal muscle: effects of plasmid DNA on the occurrence and extent of muscle damage. J Gene Med 2004; 6: 809-816.
70. Rubenstrunk A, Mahfoudi A, Scherman D. Delivery of electric pulses for DNA electrotransfer to mouse muscle does not induce the expression of stress related genes. Cell Biol Toxicol 2004; 20: 25-31.
71. Bonnafous P, Vernhes M, Teissie J, Gabriel B. The generation of reactive-oxygen species associated with long-lasting pulse-induced electropermeabilisation of mammalian cells is based on a non-destructive alteration of the plasma membrane. Biochim Biophys Acta 1999; 1461: 123-134.
72. Gabriel B, Teissie J. Control by electrical parameters of short- and long-term cell death resulting from electropermeabilization of Chinese hamster ovary cells. Biochim Biophys Acta 1995; 1266: 171-178.
73. Sabri N, Pelissier B, Teissie J. Ascorbate increases electrotransformation efficiency of intact maize cells. Anal Biochem 1998; 264: 284-286.
74. Pluen A, Boucher Y, Ramanujan S, McKee TD, Gohongi T, di Tomaso E, et al. Role of tumor-host interactions in interstitial diffusion of macromolecules: cranial vs. subcutaneous tumors. Proc Natl Acad Sci USA 2001; 98: 4628-4633.
75. Mennuni C, Calvaruso F, Zampaglione I, Rizzuto G, Rinaudo D, Dammassa E, et al. Hyaluronidase increases electrogene transfer efficiency in skeletal muscle. Hum Gene Ther 2002; 13: 355-365.
76. McMahon JM, Signori E, Wells KE, Fazio VM, Wells DJ. Optimisation of electrotransfer of plasmid into skeletal muscle by pretreatment with hyaluronidase - increased expression with reduced muscle damage. Gene Ther 2001; 8: 1264-1270.
77. Alexandrakis G, Brown E, Tong R, McKee T, Campbell R, Boucher Y, et al. Two-photon fluorescence correlation microscopy reveals the two-phase nature of transport in tumors. Nat Med 2004; 10: 203-207.
78. Kuriyama N, Kuriyama H, Julin CM, Lambom KR, Israel MA. Protease pretreatment increases the efficacy of adenovirus-mediated gene therapy for the treatment of an experimental glioblastoma model. Cancer Res 2001; 61: 1805-1809.
79. Zlotecki RA, Baxter LT, Boucher Y, Jain RK. Pharmacologic modification of tumor blood flow and interstitial fluid pressure in a human tumor xenograft network analysis and mechanistic interpretation. Microvasc 1995; 50: 429-443.
80. Yamashita Y, Shimada M, Tachibana K, Harimoto N, Tsujita E, Shirabe K, et al. In vivo gene transfer into muscle via electro-sonoporation. Hum Gene Ther 2002; 13: 2079-2084.
81. Gollins H, McMahon J, Wells KE, Wells DJ. High-efficiency plasmid gene transfer into dystrophic muscle. Gene Ther 2003; 10: 504-512.
82. Chesnoy S, Huang L, Enhanced cutaneous gene delivery following intradermal injection of naked DNA in a high ionic strength solution. Mol Ther 2002; 5: 57-62.
83. Glasspool-Malone J, Malone RW. Enhancing direct in vivo transfection with nuclease inhibitors and pulsed electrical fields. Methods Enzymol 2002; 346: 72-91.
84. Blomberg P, Eskandarpour M, Xia S, Sylven C, Islam KB. Electroporation in combination with a plasmid vector containing SV40 enhancer elements results in increased and persistent gene expression in mouse muscle. Biochem Biophys Res Commun 2002; 298: 505-510.
85. Davis HL, Whalen RG, Demeneix BA. Direct gene transfer into skeletal muscle in vivo: factors affecting efficiency of transfer and stability of expression. Hum Gene Ther 1993; 4: 151-159.
86. Bremner KH, Seymour LW, Logan A, Read ML. Factors influencing the ability of nuclear localization sequence peptides to enhance nonviral gene delivery. Bioconjug Chem 2004; 15: 152-161.
87. Efthymiadis A, Briggs LJ, Jans DA. The HIV-1 Tat nuclear localization sequence confers novel nuclear import properties. J Biol Chem 1998; 273: 1623-1628.
88. Zanta MA, Belguise-Valladier P, Behr JP. Gene delivery: a single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus. Proc Natl Acad Sci USA 1999; 96: 91-96.
89. Darquet AM, Cameron B, Wils P, Scherman D, Crouzet J. A new DNA vehicle for nonviral gene delivery: supercoiled minicircle. Gene Ther 1997; 4: 1341-1349.
90. Dancer A, Julien S, Bouillot S, Pointu H, Vernet M, Huber P. Expression of thymidine kinase driven by an endothelial-specific promoter inhibits tumor growth of Lewis lung carcinoma cells in transgenic mice. Gene Ther 2003; 10: 1170-1178
91. Kranjc S, Cemazar M, Grosel A, Scancar J, Sersa G. Electroporation of LPB sarcoma cells in vitro and tumors in vivo increases the radiosensitizing effect of cisplatin. Anticancer Res 2003; 23: 275-21.
92. Xu L, Zhao Y, Zhang Q, Li Y, Xu Y. Regulation of transgene expression in muscles by ultrasound-mediated hyperthermia. Gene Ther 2004; 11: 894-900.
93. Liang KW, Nishikawa M, Liu F, Sun B, Ye Q, Huang L. Restoration of dystrophin expression in mdx mice by intravascular injection of naked DNA containing full-length dystrophin cDNA. Gene Ther 2004; 11: 901-90
94. Wolff JA, Malone RW, Williams P, Chong W, Acsadi G, Jani A, et al. Direct gene transfer into mouse muscle in vivo. Science 1990; 247: 1465-1468.
95. Hagstrom J, Hegge J, Zhang G Noble M, Budker V, Lewis DL, et al. A facile nonviral method for delivering genes and siRNAs to skeletal muscle of mammalian limbs. Mol Ther 2004; 10: 386-398.
96. Bureau MF, Naimi S Torero Ibad R, Seguin J, Georger C, Arnould E, et al. Intramuscular plasmid DNA electrotransfer: biodistribution and degradation. Biochim Biophys Acta 2004; 1676: 138-148.
97. Nicol F, Wong M, MacLaughlin, FC, Perrard J, Wilson E, Nordstrom JL, et al. Poly-L-glutamate, an anionic polymer, enhances transgene expression for plasmids delivered by intramuscular injection with in vivo electroporation. Gene Ther 2002; 9: 1351-1358.
98. Wang Y, Bai Y, Price C, Boros P, Qin L, Bielinska AU, et al. Combination of electroporation and DNA/dendrimer complexes enhances gene transfer into murine cardiac transplants. Am J Transplant 2001; 1: 334-338.
99. Hartikka J, Bozoukova V, Jones D, Mahajan R, Wloch MK, Sawdey M, et al. Sodium phosphate enhances plasmid DNA expression in vivo. Gene Ther 2000; 7: 1171-82.
100. Lee MJ, Cho SS, Jang HS, Lim YS, You JR, Park J, et al. Optimal salt concentration of vehicle for plasmid DNA enhances gene transfer mediated by electroporation. Exp Mol Med 2002; 34: 265-272.
101. Wang Z, Troilo, PJ, Wang X, Griffiths TG, Pacchione SJ, Barnum AB, et al. Detection of integration of plasmid DNA into host genomic DNA following intramuscular injection and electroporation. Gene Ther 2004; 11: 711-721.
102. Babiuk S, Baca-Estrada, ME, Foldvari M, Middleton DM, Rabussay D, Widera G, et al. Increased gene expression and inflammatory cell infiltration caused by electroporation are both important for improving the efficacy of DNA vaccines. J Biotechnol 2004; 110: 1-10.
103. Sersa G, Kotnik V, Cemazar M, Miklavcic D, Kotnik A. Electrochemotherapy with bleomycin in SA-1 tumor-bearing mice - natural resistance and immune responsiveness. Anticancer Drugs 1996; 7: 785-791.
104. Braun S, Thioudellet C, Rodriguez P, Ali-Hadji D, Perraud F, Accart N, et al. Immune rejection of human dystrophin following intramuscular injections of naked DNA in mdx mice. Gene Ther 2000; 7: 1447-1457.
105. Katsumi A, Emi N, Abe A, Hasegawa Y, Ito M, Saito H. Humoral and cellular immunity to an encoded protein induced by direct DNA injection. Hum Gene Ther 1994; 5: 1335-1339.
106. McCluskie MJ, Davis HL. CpG DNA is a potent enhancer of systemic and mucosal immune responses against hepatitis B surface antigen with intranasal administration to mice. J Immunol 1998; 161: 4463-4466.
107. Babiuk LA, Pontarollo R, Babiuk S, Loehr B, van Drunen Littelvan den Hurk S. Induction of immune responses by DNA vaccines in large animals. Vaccine 2003; 21: 649-658.
108. Paster W, Zehetner M, Kalat M, Schuller S, Schweighoffer T. In vivo plasmid DNA electroporation generates exceptionally high levels of epitope-specific CD8+ T-cell responses. Gene Ther 2003; 10: 717-724.
109. Gehl J, Skovsgaard T, Mir LM. Vascular reactions to in vivo electroporation: characterization and consequences for drug and gene delivery. Biochim Biophys Acta 2002; 1569: 51-58.
110. Sersa G, Cemazar M, Parkins CS, Chaplin DJ. Tumour blood flow changes induced by application of electric pulses. Eur J Cancer 1999; 35: 672-677.
111. Takeshita S, Isshiki T, Sato T. Increased expression of direct gene transfer into skeletal muscles observed after acute ischemic injury in rats. Lab Invest 1996; 74: 1061-1065.
112. Coralli C, Cemazar M, Kanthou C, Tozer GM, Dachs GU. Limitations of the reporter green fluorescent protein under simulated tumor conditions. Cancer Res 2001; 61: 4784-4790.